GI
AUTL

GAMMA Investing’s Autolus Therapeutics AUTL Stock Holding History

GAMMA Investing’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Buy
15,499
+8,309
+116% +$13K ﹤0.01% 2724
2026
Q1 		$9.92K Sell
7,190
-2,995
-29% -$4.55K ﹤0.01% 3073
2025
Q4 		$20.3K Buy
10,185
+774
+8% +$1.19K ﹤0.01% 2610
2025
Q3 		$15.3K Sell
9,411
-634
-6% -$1.24K ﹤0.01% 2658
2025
Q2 		$22.9K Buy
10,045
+3,188
+46% +$5.27K ﹤0.01% 2385
2025
Q1 		$10.6K Buy
6,857
+2,327
+51% +$4.72K ﹤0.01% 2717
2024
Q4 		$10.6K Buy
4,530
+1,670
+58% +$5.64K ﹤0.01% 2580
2024
Q3 		$10.4K Buy
2,860
+1,391
+95% +$5.55K ﹤0.01% 2442
2024
Q2 		$5.11K Buy
1,469
+411
+39% +$1.77K ﹤0.01% 2565
2024
Q1 		$6.75K Buy
1,058
+751
+245% +$4.68K ﹤0.01% 2259
2023
Q4 		$1.85K Buy
+307
New +$1.17K ﹤0.01% 2601

Other funds holding AUTL

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
QFPL
QUANTUM FINANCIAL PARTNERS LLC Overland Park, Kansas $196M AUM
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

GAMMA Investing's AUTL Position: Q2 2026 in Review

GAMMA Investing increased its Autolus Therapeutics (AUTL) stake by 116% in Q2 2026, buying an estimated $13K and bringing the position to 15,499 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

GAMMA Investing first reported a position in AUTL in Q4 2023 and has held it in 11 quarters since. 5 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • GAMMA Investing held 15,499 shares of Autolus Therapeutics worth $24.8K as of Q2 2026.
  • GAMMA Investing bought 8,309 Autolus Therapeutics shares in Q2 2026, an estimated $13K.
  • Autolus Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2724 holding.
  • GAMMA Investing first reported a position in Autolus Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 5 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.